Xcopri
| Chemical Name | cenobamate |
| Dosage Form | Tablet (oral; 12.5 mg, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg) |
| Drug Class | Inhibitors |
| System | Nervous |
| Company | SK Life Science |
| Approval Year | 2019 |
Indication
- Xcopri is indicated for the treatment of partial-onset seizures in adult patients.